A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Summary

N-cadherin, a protein involved in blood vessel cell binding, is increased as cancer progresses, and is on the surface of many tumor cells. ADH-1 blocks N-cadherin. This study will test the safety and effects of ADH-1 in subjects with specific incurable, solid tumors with a protein biomarker called N-cadherin. This study will examine the clinical activity of ADH-1.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications